Commentary.

J Neurosci Rural Pract

McLean Hospital, Department of Psychiatry, Belmont, MA, USA ; Harvard Medical School, Department of Psychiatry, Boston, MA, USA.

Published: September 2012

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505317PMC

Publication Analysis

Top Keywords

commentary
4
commentary
1

Similar Publications

Addressing Improper Medicine Storage Practices: Commentary on Louhisalmi et  al.'s Study.

Basic Clin Pharmacol Toxicol

February 2025

Department of Addiction Psychiatry, Taoyuan Psychiatric Center, Ministry of Health and Welfare, Taoyuan City, Taiwan.

View Article and Find Full Text PDF

SGLT-2 inhibitors and diabetic ketoacidosis.

Intern Emerg Med

January 2025

Department of Internal Medicine, Ospedale Fatebenefratelli, ASST Fatebenefratelli-Sacco, Piazzale Principessa Clotilde n 3, 20121, Milan, Italy.

View Article and Find Full Text PDF

Neoadjuvant or perioperative immunotherapy for resectable melanoma: The need for biomarkers.

Eur J Cancer

January 2025

National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. Electronic address:

Groundbreaking studies have reshaped the treatment landscape for patients with resectable stage ≥IIIB melanoma by demonstrating the benefits of neoadjuvant therapy. Data from the NADINA and SWOG S1801 trials reveal substantial improvements in event-free survival compared to adjuvant therapy alone. These studies employed distinct neoadjuvant immunotherapy approaches - ipilimumab plus nivolumab in NADINA and anti-PD-1 monotherapy in SWOG S1801 - highlighting potential differences in efficacy and toxicity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!